Avivagen Announces Completion of Share Consolidation
(WorldNews Canada)

OTTAWA, May 24, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces that, following the approval of the Corporation´s shareholders obtained April 11, 2017, the Corporation has consolidated its issued and outstanding shares (the `Shares`) at a ratio of ten (10) pre-consolidation common shares to one (1) post-consolidation common share (the `Consolidation`) effective as of May 12, 2017. No fractional common shares will be issued as a result of the Consolidation. The holdings...